Siler root

Siler Root (Saposhnikovia divaricata): A Comprehensive Reference

1. Identity and Botanical Description

1.1 Taxonomy and Nomenclature

Siler root belongs to Saposhnikovia, a monotypic genus of flowering plants in the family Apiaceae. Its only species is Saposhnikovia divaricata, known as fángfēng (防風, literally "protect against the wind") in Chinese, bangpung in Korean, and siler in English. The plant is still frequently referenced under the obsolete genus name Ledebouriella in many online sources devoted to traditional Chinese medicine. It was first described as Stenocoelium divaricatum by Nikolai Turczaninow in 1844, and transferred to Saposhnikovia in 1951. Additional synonyms encountered in the literature include Siler divaricatum, Ledebouriella divaricata, and Ferula seseloides.

The full accepted binomial is Saposhnikovia divaricata (Turcz. ex Ledeb.) Schischk. The pharmacopoeial drug name is Radix Saposhnikoviae, referring to the dried root. Health Canada's Traditional Chinese Medicine Ingredients database lists the proper name as Saposhnikovia divaricata with the common Pinyin name Fang feng and pharmacopoeial name Radix Saposhnikoviae.

1.2 Botanical Description

Saposhnikovia divaricata (Apiaceae) is a perennial mono-carpic herbaceous plant, the only species of the Far Eastern, Daurian, and Mongolian genus Saposhnikovia Schischk. It is a glabrous, much-branched perennial herb in the Apiaceae (celery/carrot) family and the sole species in its genus. The plant grows 30 to 100 cm tall from a thick, branched, tuberous rootstock up to 2 cm in diameter. The crown of the rootstock is surrounded by fibrous remnants of old leaf-sheath bases, forming the characteristic "broom head" (扫帚头) visible on the harvested drug. Basal leaves are numerous, with flattened petioles and oblong-ovate to broadly ovate blades that are bi- to tri-pinnatifid, with 3 to 4 pairs of pinnae and lanceolate terminal lobes. Leaves become smaller further up the stem. Numerous compound umbels appear at the stem tips, about 6 cm across, with 5 to 7 rays bearing small white flowers. The fruit (cremocarp) is narrowly oblong to elliptical, 4 to 5 mm long, with warty bumps when young that smooth out as it matures.

1.3 Geographic Distribution

Saposhnikovia divaricata Schischk., a perennial herb belonging to the family Umbelliferae, is widely distributed in Northeast Asia. This hardy plant thrives in cool climates and can withstand both cold and drought. It is primarily cultivated in northern and northeastern China, including regions like Hebei, Heilongjiang, Sichuan, and Inner Mongolia. Additional producing regions within China include Shanxi, Jilin, Anhui, Gansu, and other provinces.

1.4 Common Forms and Preparations

When it comes to medicinal use, it is all about the roots. The dried root of Saposhnikovia, known as Radix Saposhnikoviae in Latin, is the part used in traditional Chinese medicine (TCM). The root is cone-shaped or spindle-shaped, about 8–12 inches long, with a grayish-yellow or grayish-brown exterior.

The root is encountered commercially and clinically in a number of forms:

• Decoctions (water extracts): The most classical preparation in TCM, prepared by simmering the dried root slices in water.
• Powdered root (ground dried root): In some regions of China, the dried and powdered root was added to herbal soups, broths, and meat dishes, especially during the fall and winter months.
• Standardized extracts: Modern preparations include ethanol, methanol, and aqueous extracts standardized to chromone content, used in research and clinical formulations.
• Pills and granules: Included as one of multiple herbs in traditional multi-herb formulas prepared as pills or granules according to the Chinese Pharmacopoeia.
• Tinctures and glycerites: Alcohol-based tinctures and alcohol-free glycerin-based extracts are available as contemporary supplement forms.

There are two main market specifications of the drug: wild and cultivated, categorized by shape, color, texture, and cross-section. The roots are widely used in China, Korea, and Japan. The high demand of S. divaricata products has raised the problem of sustainable use and conservation of the species due to the mass and unregulated harvesting of its roots.

2. Traditional and Historical Use

2.1 Origins in Chinese Medicine

For over 2,000 years, the roots of Saposhnikovia divaricata have been an important component of Oriental Traditional Medicine. The first mention of their use is found in the oldest Chinese treatise on medicinal plants, Shen Nong Ben Cao Jing, according to which the dried roots of this plant are called "Fang Feng" in China (which means "dispelling wind") and belong to the highest class of medicinal plant raw materials, due to its ability to use in treatment of pathogenic conditions "wind," "dampness," and "cold" — concepts of Oriental Traditional Medicine.

Its root has been used since the Western Han Dynasty (202 B.C.). With a history of over 2,000 years in traditional Chinese medicine clinical practice, it is a medicinal herb widely produced in various regions of China. Saposhnikovia divaricata is recorded as a superior herb in the ancient book Shennong Bencao Jing. Its traditional functions include dispelling wind, relieving surface symptoms, eliminating dampness, alleviating pain, and relieving spasms.

2.2 TCM Classification and Theoretical Framework

In traditional Chinese medicine, fangfeng is classified as a wind-dispelling herb, meaning it helps the body protect itself against seasonal infections, colds, fever, and muscle and joint pain. In TCM, siler root is part of the Apiaceae (carrot) family and is recognized for its sweet, slightly spicy flavor and its ability to "expel wind" — a central concept in TCM relating to pathogenic influences like colds, fevers, and joint pain. Siler root is traditionally used as a diaphoretic (sweat-inducing), antipyretic (fever-reducing), and anti-inflammatory herb.

Radix Saposhnikoviae, commonly known as FangFeng, is a renowned medicinal herb in China extensively utilized in traditional Chinese medicine. It expels pathogenic wind from the body surface, alleviates pain by removing dampness, and relieves convulsion. Therefore, it is mainly used for treating exterior syndrome, itchy wind papules, rheumatic arthralgia, and splenic asthenia-induced dampness.

Native to Northern China, Siberia, the Korean Peninsula, and the Russian Far East, this plant is a well-established herb in Traditional Chinese Medicine. The herb is considered warming and drying in nature, with tastes described as pungent, sweet, and bitter. Its energetic actions promote ascending and outward movement, classified as tonifying qi.

2.3 Conditions Treated Historically

The roots of this plant are widely used in China, Korea, and Japan as an effective anti-inflammatory for arthralgia, rheumatism, generalized ache and headaches, strokes, fevers, colds and allergic rhinitis, as well as an analgesic, anti-Parkinsonian, and in multi-component herbal preparations.

The Pharmacopoeia of the People's Republic of China records that Saposhnikoviae Radix can be used for treating the common cold and headache, rheumatic arthralgia, rubella and itching, tetanus, and other diseases.

Saposhnikovia divaricata is one of the valuable and famous traditional Chinese medicine plants listed in several pharmaceutical records, such as the Chinese Pharmacopoeia and Shen Nong's Materia Medica.

S. divaricata was first recorded in the Shennong's Classic of Materia Medica, which was written in 300 AD China. It is generally prescribed to use SD to dispel wind to release the exterior pattern, dispel dampness, relieve pain, and to arrest convulsions, which is roughly in line with modern applications.

2.4 Cultural and Culinary Context

Although fangfeng is not a commonly used culinary herb, it has found its place in Asian traditions for centuries as an ingredient in dishes that strengthen the body. In ancient culinary and medicinal recipes, there was no clear line between food and medicine — therefore, fangfeng root was treated both as a spice and as a health agent. In some regions of China, the dried and powdered root was added to herbal soups, broths, and meat dishes, especially during the fall and winter months. It was believed to strengthen the immune system, protect against colds, and warm the body.

2.5 Use in Korea and Japan

Saposhnikovia divaricata is a commonly used traditional herb in East Asia. Its Korean name, bangpung, retains the same meaning — "prevention against wind." The root appears in Korean traditional medicine (hanbang) and Japanese Kampo medicine, where it features in compound formulas for conditions analogous to those in TCM.

SD is widely used in the clinic, and about 8% of prescriptions in the Chinese Pharmacopoeia contain SD. S. divaricata (SADS) is classified as a special-grade traditional Chinese medicine in Shennong's Materia Medica due to its immune-protective effects. Over 130 traditional Chinese medicine formulations containing SADS are used for RA treatment.

3. Key Constituents and Active Compounds

3.1 Overview of Phytochemical Classes

Its dried root (Radix Saposhnikoviae) is used as a Chinese herbal medicine for the treatment of immune system, nervous system, and respiratory diseases. Phytochemical and pharmacological studies have shown that the main constituents of S. divaricata are chromones, coumarins, acid esters, and polyacetylenes, and these compounds exhibited significant anti-inflammatory, analgesic, antioxidant, antiproliferative, antitumor, and immunoregulatory activities.

Studies have discovered that Saposhnikovia divaricata contains chemical components such as chromones, polysaccharides, volatile oils, and coumarins. These components exhibit pharmacological activities such as antipyretic, anti-inflammatory, analgesic, and anti-tumor effects.

3.2 Chromones

Chromones, a subclass of flavonoids, are a class of oxygen-containing heterocyclic compounds having a benzo-cyclized γ-pyrone ring. They are the primary active components of S. divaricata, and research on these compounds has been more extensively studied than that on other components.

Prim-O-glucosylcimifugin, cimifugin, and 5-O-methylvisamminoside are three major chromone derivatives of Saposhnikovia divaricata that have many pharmacological activities, such as anti-inflammatory and antitumor activities.

Two chromones, prim-O-glucosylcimifugin (cimifugin β-D-glucopyranoside) and 4′-O-β-D-glucosyl-5-O-methylvisamminol, which are considered to be mainly responsible for the activity of this raw material, were selected as reference compounds for the identification and quality assessment of Saposhnikoviae Radix.

Additional individual compounds identified from roots include 3′-O-angeloylhamaudol, isobergapten, imperatorin, anomalin, decursin, xanthotoxin, bergapten, tectochrysin, scopoletin, hamaudol, ledebouriellol, cimifugin, sec-O-glucosylhamaudol, 4′-O-β-D-glucosyl-5-O-methylvisamminol, and prim-O-glucosylcimifugin. These include chromones (positions 1 and 13–18), coumarins (positions 2, 3, 5–10, and 12), a fatty acid (position 4), and a flavonoid (position 11).

Studies have shown that prim-O-glucosylcimifugin and 4′-O-β-D-glucosyl-5-O-methylvisamminol can not only effectively inhibit a variety of stimuli causing pain in mice, but can also effectively reduce xylene-induced ear swelling in mice. Cimifugin has good antipyretic, analgesic, and anti-inflammatory effects.

3.3 Coumarins

Chromones and coumarins are the pharmacologically active substances in S. divaricata. Modern phytochemical and pharmacological studies have demonstrated their antipyretic, analgesic, anti-inflammatory, antioxidant, anti-tumor, and anticoagulant activities.

Key individual coumarin compounds include scopoletin, bergapten, isoimperatorin, marmesin, (+)-decursinol, (−)-praeruptorin B, and oxypeucedanin hydrate. The root also contains phenolic acids and furanocoumarins. Chlorogenic acid, rosmarinic acid, and imperatorin demonstrated strong radical scavenging, while prim-O-glucosylcimifugin showed a weaker response; no scavenging was observed for cimifugin and 4′-O-β-D-glucosyl-5-O-methylvisamminol in the DPPH model.

3.4 Polysaccharides

Radix Saposhnikoviae has important medicinal value, and the polysaccharide component is one of its important active ingredients. A polysaccharide named SP800201 with a molecular weight of 2.17 × 10⁵ g/mol has been isolated from Saposhnikoviae Radix. The monosaccharide composition of SP800201 mainly contains galactose (Gal), galacturonic acid (GalA), arabinose (Ara), and rhamnose (Rha). SP800201 has a core structure containing GalA as the backbone and side chains consisting of GalA, Gal, Ara, and Rha.

Two additional purified native polysaccharides, SDNP-1 and SDNP-2, with apparent molecular weights of 67.9 × 10³ and 5.2 × 10³, respectively, were isolated from the water extract of Saposhnikovia divaricata. The structures were characterized by HPGPC, chemical derivative analysis, GC–MS, FT-IR, and NMR spectroscopy. Both SDNP-1 and SDNP-2 were composed of arabinose and galactose with molar ratio of approximately 1:1 and deduced to be AGII-type arabinogalactans.

3.5 Polyacetylenes and Other Minor Constituents

By activity-oriented separation using the writhing method in mice, the analgesic components of Saposhnikovia root were identified to be chromones, coumarins, polyacetylenes, and 1-acylglycerols. The lipophilic fraction of the root also contains significant amounts of linolenic acid (ALA), docosahexaenoic acid (DHA), linoleic acid (LA), and oleic acid (OA), as identified by HPLC fingerprint analysis.

4. Mechanisms of Action

4.1 Anti-Inflammatory Pathways

The therapeutic efficacy of S. divaricata is largely attributable to a complex mixture of bioactive compounds — predominantly chromones and coumarins. These molecules modulate key immunological pathways, including the suppression of pro-inflammatory cytokines and inhibition of pivotal signalling cascades such as NF-κB.

Saposhnikovia divaricata extract (SDE) showed anti-inflammatory activity by inhibiting the production of nitric oxide (NO), prostaglandin E2 (PGE2), tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6) in LPS-induced RAW 264.7 cells.

Prim-O-glucosylcimifugin (POG) is one of the main active substances of Saposhnikovia chromone, which can reduce the inflammatory reaction of RAW 264.7 macrophage induced by lipopolysaccharide.

Mechanistic studies have demonstrated that prim-O-glucosylcimifugin can ameliorate inflammatory conditions, as evidenced in murine models of lung injury.

Network pharmacology analysis showed that SADS may play a role in the treatment of rheumatoid arthritis through the TNF and RAGE (Receptor for Advanced Glycation End-products) signaling pathways.

4.2 Analgesic Mechanisms

The most potent analgesia among isolated compounds was observed in the chromones divaricatol, ledebouriellol, and hamaudol, which inhibited writhing in mice at an oral dose of 1 mg/kg. In pharmacological tests using sec-O-glucosylhamaudol, the compound showed analgesia by the tail pressure and the Randall & Selitto methods, and its writhing inhibition was not reversed by naloxone, suggesting a non-opioid mechanism of action.

4.3 Immunomodulatory Mechanisms

In vitro RAW264.7 cell experiments showed that polysaccharide SP800201 could significantly improve the proliferation and phagocytosis of macrophages and promote the release of NO, TNF-α, IL-1β, and IL-6. In vivo experiments in immunocompromised zebrafish showed that the same polysaccharide could significantly increase the density of immune cells and the number of macrophages. These results showed that the Saposhnikoviae Radix polysaccharide has certain immunomodulatory activity.

4.4 Atopic Dermatitis / Allergy Mechanisms

The Schizonepeta-Saposhnikovia water extract (JF-WE) suppressed TRPV1 expression in macrophages, potentially by affecting NF-κB p65 phosphorylation rather than the JAK-STAT6 pathway. This study offers initial evidence of the effectiveness of JF-WE in suppressing inflammation in atopic dermatitis, with the therapeutic effect stemming from its ability to downregulate TRPV1 expression and subsequent NF-κB p65 phosphorylation in macrophages.

5. Scientific Evidence by Area of Application

Overall note on evidence base: The vast majority of current pharmacological evidence for siler root is derived from in vitro cell studies and in vivo animal models. Robust, large-scale randomized controlled trials in human populations are largely absent. A 2020 review article evaluates a collection of works on in vitro and biochemical studies of S. divaricata, noting that the discourse on the diverse class of chromones and coumarins offers insight into pharmacological effects including anti-inflammatory, analgesic, immunoregulatory, antioxidative, and anti-proliferative activity. Where human/clinical data exist, they are noted specifically below.

5.1 Inflammation and Arthritis

Preclinical evidence: The anti-inflammatory effect of Saposhnikovia divaricata extract (SDE) was evaluated in vitro in lipopolysaccharide-(LPS-) treated RAW 264.7 cells. The antiosteoarthritic effect of SDE was investigated in an in vivo rat model of monosodium iodoacetate-(MIA-) induced osteoarthritis (OA), in which rats were treated orally with SDE (200 mg/kg) for 28 days. The effects of SDE were assessed by histopathological analysis and by measuring weight-bearing distribution, cytokine serum levels, and joint tissue inflammation-related gene expression.

Modern pharmacological studies have shown that S. divaricata has good anti-inflammatory and immune regulating effects, and can effectively relieve rheumatoid arthritis and regulate the metabolic disorder of collagen-induced arthritis rats.

SADS is classified as a special-grade traditional Chinese medicine due to its immune-protective effects. Over 130 traditional Chinese medicine formulations containing SADS are used for RA treatment. However, the active ingredients and serum metabolites of SADS remain underexplored, and its precise mechanism of action in RA is not fully understood.

A total of 5,536 compounds were identified in SADS in one analysis, with 19 active components finally selected. In serum metabolites following SADS administration, 4,945 compounds were identified, of which 17 showed anti-inflammatory activity.

Evidence strength: Preclinical (in vitro and animal) evidence is substantial, but no rigorous controlled human clinical trials have established efficacy for arthritis specifically. Evidence is preliminary.

5.2 Analgesic and Antipyretic Effects

Preclinical evidence: By activity-oriented separation using the writhing method in mice, the analgesic components of Saposhnikovia root were identified to be chromones, coumarins, polyacetylenes, and 1-acylglycerols. Two new components, divaricatol and (3′S)-hydroxydeltoin, were also isolated. The most potent analgesia was observed in chromones such as divaricatol, ledebouriellol, and hamaudol, which inhibited writhing at an oral dose of 1 mg/kg in mice. Acylglycerols also showed significant inhibition at a dose of 5 mg/kg.

Modern phytochemical and pharmacological studies have demonstrated the antipyretic and analgesic activities of the chromones and coumarins.

Evidence strength: Animal and in vitro data only. No controlled human analgesic or antipyretic trials identified in the peer-reviewed literature.

5.3 Immune System and Allergic Disease

Preclinical/mixed evidence: Saposhnikovia divaricata, called 'Fangfeng' in China, is an active ingredient in about 8% of TCM prescriptions. However, its effects on type I allergy and pseudoallergy had not been fully clarified. One study aimed to explore the treatment and potential mechanisms of SD and its major bioactive component prim-O-glucosylcimifugin (POG) on type I allergy and pseudoallergy in vitro and in vivo.

An in vitro inflammation model was created based on LPS-stimulated RAW264.7 cells to detect nitrite concentration and the levels of TNF-α, IL-13, IL-31, and IL-33. Compared with the model group, mice in the high, medium, and low-dose cimifugin groups showed significantly alleviated atopic dermatitis-like symptoms. The expression levels of inflammatory factors in mouse serum and skin homogenate significantly decreased (p < 0.01, p < 0.001).

The Schizonepeta tenuifolia–Saposhnikovia divaricata (Jingjie-Fangfeng, JF) combination has been used for years to treat allergic inflammatory skin diseases like atopic dermatitis.

Evidence strength: Preclinical and animal data indicate anti-allergic activity, but the human clinical evidence is limited to small observational studies of multi-herb formulas rather than siler root as a single agent.

5.4 Antitumor / Anti-Proliferative Effects

Preclinical evidence: Saposhnikovia divaricata has been used in traditional Chinese medicine to treat pain, inflammation, and arthritis. It has been reported that SD extract may inhibit tumor growth, but the mechanism involved was elusive. One study investigated the anti-tumor activity of polysaccharides derived from SD in breast cancer and the underlying mechanisms.

In vitro studies showed that SD polysaccharides (SDPs) promoted U937 cell growth dose-dependently, with no obvious effect on growth of breast cancer cell lines MCF-7 and MDA-MB-231 directly. These polysaccharides potently promoted the growth of U937 (monocyte/macrophage-like) cells and activated them to inhibit the tumor growth of SCID mice bearing MDA-MB-231-derived xenograft tumors indirectly, with no obvious growth inhibition effects on MCF-7 and MDA-MB-231 cells themselves.

Evidence strength: Very preliminary; evidence is restricted to in vitro cell lines and mouse xenograft models. No human clinical oncology evidence exists for siler root.

5.5 Inflammatory Bowel Disease

Preclinical evidence: The root of Saposhnikovia divaricata contains various bioactive compounds with anti-inflammatory, antioxidant, and analgesic properties. However, no scientific studies have validated its clinical use as an anti-inflammatory agent against inflammatory bowel disease (IBD). One study aimed to investigate whether the root extract of S. divaricata ameliorates IBD and induces gut microbial alteration, using a RAW 264.7 cell line and a DSS-induced colitis mouse model.

Evidence strength: Preclinical animal and cell-line data only; investigators themselves state that clinical validation is lacking.

5.6 Neurological Effects (Anticonvulsant)

Siler root is used in traditional preparations as an anti-Parkinsonian agent and for relief of convulsions, a use noted across traditional Chinese, Korean, and Japanese medicine. Its traditional functions include dispelling wind, relieving surface symptoms, eliminating dampness, alleviating pain, and relieving spasms. Preclinical studies on anticonvulsant activity have been conducted in comparative studies on water extracts from wild and cultivated roots, but the human clinical evidence for any neurological indication remains absent from the peer-reviewed literature.

5.7 Skin Conditions (Dermatology)

A clinical observation reported that Shufeng Liangxue Decoction (a formula containing divaricate saposhnikovia root) is effective and safe in treating hormone-dependent dermatitis, with efficacy better and relapse rate lower than treatment with Western medicine alone. This represents multi-herb formula evidence rather than a single-agent study. Traditional uses also include skin diseases such as eczema and psoriasis, especially with itching.

Evidence strength: One small Chinese-language clinical observation (compound formula); no single-herb RCTs identified. Preclinical mechanism data are available for the atopic dermatitis indication.

5.8 Antioxidant Activity

The root contains phenolic acids, chromones, and furanocoumarins. Chlorogenic acid, rosmarinic acid, and imperatorin demonstrated strong radical scavenging activity in DPPH assays. Anti-aging ability of the lipophilic components was preliminarily studied using the Caenorhabditis elegans model. This evidence is limited to in vitro and model organism experiments.

6. Body Systems and Health Areas Associated with Siler Root

• Musculoskeletal / Rheumatological: Historically and in current TCM practice for arthralgia, rheumatoid arthritis, and muscle pain. Preclinical evidence of anti-inflammatory and antiarthritic effects through NF-κB and MAPK inhibition.
• Immune System: Used traditionally to "strengthen the exterior" against pathogens. In vitro and animal data support immunomodulatory effects mediated by polysaccharides and chromones on macrophage activity.
• Integumentary (Skin): Traditional use for urticaria, eczema, pruritus, and allergic skin conditions. Preclinical data on atopic dermatitis via TRPV1/NF-κB suppression.
• Respiratory: The dried root (Radix Saposhnikoviae) is used as a Chinese herbal medicine for the treatment of immune system, nervous system, and respiratory diseases.
• Neurological: Traditional use for tremors, spasms, headache, and analgesic purposes; anticonvulsant effects demonstrated in animal models but not in human trials.
• Gastrointestinal: Preclinical data suggest potential in inflammatory bowel conditions, though clinical evidence is absent.

7. Dosage Forms and Reported Dosages

The following dosages are as reported in the scientific literature or pharmacopoeial references and are presented purely as factual data from those sources.

• Traditional decoction dose (Chinese Pharmacopoeia context): Fangfeng (Saposhnikoviae Radix), derived from the dried roots of Saposhnikovia divaricata Schischk., is recorded in the Pharmacopoeia of the People's Republic of China for treating the common cold and headache, rheumatic arthralgia, rubella and itching, tetanus, and other diseases. The Chinese Pharmacopoeia (2020 edition) specifies prim-O-glucosylcimifugin and 5-O-methylvisammioside as the primary reference markers for quality control.
• Preclinical study dosages (animal):
  • The antiosteoarthritic effect of SDE was investigated in a rat model of MIA-induced osteoarthritis in which rats were treated orally with SDE (200 mg/kg) for 28 days.
  • The most potent chromone analgesics (divaricatol, ledebouriellol, hamaudol) inhibited writhing at an oral dose of 1 mg/kg in mice. Acylglycerols showed significant inhibition at a dose of 5 mg/kg.
• Quality markers in pharmacopoeia: The Chinese Pharmacopoeia 2020 identifies prim-O-glucosylcimifugin and 5-O-methylvisammioside as the primary active plant metabolites for Saposhnikovia divaricata.
• Traditional formula context: SD is mostly used in compound preparations in the clinic. As a component herb in multi-ingredient TCM decoctions, dosages of the individual root vary by formula and practitioner prescription.

No established human clinical dose-finding trials for siler root as a single agent were identified in the peer-reviewed literature at the time of this article's preparation.

8. Safety Considerations

8.1 General Toxicological Profile

In cytotoxicity testing of isolated chromone and coumarin compounds from S. divaricata, all tested compounds were non-toxic in the hemolysis test.

Modern phytochemical and pharmacological studies have demonstrated the antipyretic, analgesic, anti-inflammatory, antioxidant, anti-tumor, and anticoagulant activities of the root's main constituents; the anticoagulant activity noted in the literature for coumarins is a pharmacologically relevant finding with safety implications for concurrent use with anticoagulant drugs.

8.2 Conservation Status and Adulteration Risk

The natural habitat of S. divaricata is rapidly declining owing to the harvesting of its roots. The high demand of S. divaricata products has raised the problem of sustainable use and conservation of the species due to the mass and unregulated harvesting of its roots. This supply pressure can increase the likelihood of adulteration or substitution with related species in commercial preparations.

8.3 Traditional Contraindications

TCM practice identifies several categories of patients or conditions where siler root is traditionally considered inappropriate or contraindicated:

• S. divaricata is classified as a special-grade traditional Chinese medicine due to its immune-protective effects, including dispelling cold, relieving edema and pain; accordingly, TCM frameworks contraindicate it where heat excess (rather than cold/wind) is the underlying pattern.
• TCM frameworks also historically note caution in conditions characterized by Yin deficiency with heat signs, liver yang rising, and conditions where spontaneous sweating from underlying deficiency is present — reflecting the herb's diaphoretic and wind-dispersing properties.
• Traditional herb incompatibilities mentioned in classical TCM sources include concurrent use with Li Lu (veratrum root), which is cited in TCM incompatibility doctrine.

8.4 Pharmacological Safety Signals

Chromones and coumarins are the pharmacologically active substances in S. divaricata. Modern pharmacological studies have demonstrated anticoagulant activities alongside the anti-inflammatory and analgesic properties. The presence of furanocoumarins such as bergapten and isoimperatorin is pharmacologically significant: furanocoumarins are established inhibitors of cytochrome P450 enzymes (notably CYP3A4 and CYP1A2) and have photosensitizing potential. These properties may be relevant for drug interactions, though direct human pharmacokinetic interaction studies with siler root specifically were not identified in the sources reviewed.

Most pharmacological investigations have been limited to the main active substances — chromones and coumarins. Researchers have proposed that future research should focus on components' synergistic effects, indicating that the full safety profile of the whole root matrix remains incompletely characterized.

8.5 Evidence Gaps in Safety Research

While the root contains various bioactive compounds with anti-inflammatory, antioxidant, and analgesic properties, no scientific studies have validated its clinical use as an anti-inflammatory agent in human populations for conditions such as IBD. The lack of controlled human trials extends to safety: formal dose-escalation, interaction, and pregnancy safety studies in humans are absent from the peer-reviewed literature identified in this review. Traditional contraindications in pregnancy exist within TCM frameworks but have not been studied in modern clinical designs.

References

• Saposhnikovia divaricata — An Ethnopharmacological, Phytochemical and Pharmacological Review (PMC, 2020)
• Saposhnikoviae divaricata: a phytochemical, pharmacological, and pharmacokinetic review (PMC, 2020)
• Advances in Phytochemistry and Modern Pharmacology of Saposhnikovia Divaricata (Turcz.) Schischk — Chinese Journal of Integrative Medicine (Springer, 2023)
• Anti-Inflammatory and Antiosteoarthritis Effects of Saposhnikovia divaricata Ethanol Extract: In Vitro and In Vivo Studies (PMC, 2016)
• Analgesic components of saposhnikovia root (Saposhnikovia divaricata) — Chemical & Pharmaceutical Bulletin (PubMed, 2001)
• Network pharmacology-based analysis of the mechanism of Saposhnikovia divaricata for the treatment of type I allergy (PMC, 2022)
• Polysaccharides Derived from Saposhnikovia divaricata May Suppress Breast Cancer Through Activating Macrophages (PMC, 2020)
• Schizonepeta tenuifolia Briq–Saposhnikovia divaricata Decoction Alleviates Atopic Dermatitis via Downregulating Macrophage TRPV1 (PMC, 2024)
• Aqueous extract of Saposhnikovia divaricata root alleviates rheumatoid arthritis by acting on TNF-α and RAGE signaling pathways (PMC, 2025)
• Transcriptomics explores the potential of flavonoid in non-medicinal parts of Saposhnikovia divaricata (Turcz.) Schischk — Frontiers in Pharmacology (PMC, 2022)
• Study on HPLC fingerprint of Saposhnikovia divaricata lipophilic components and anti-aging effects (PMC, 2024)
• Determining Antiradical Capacity of Medicinal Plant Extract Individual Constituents Using Post-Column Reaction Method (PMC, 2024)
• Anti-Inflammatory Pharmacological Mechanism of Fangfeng in Rheumatoid Arthritis Models Based on Serum Metabolomics and Network Pharmacology (PMC, 2025)
• Purification, structure characterization and antioxidant activity of polysaccharides from Saposhnikovia divaricata (ScienceDirect, 2019)
• Study on the mechanism of action of Saposhnikovia divaricata and its key phytochemical on rheumatoid arthritis based on network pharmacology and bioinformatics (ScienceDirect, 2024)
• Structural characterization of polysaccharides from Saposhnikovia divaricata and their antagonistic effects on RAW264.7 macrophages (ScienceDirect, 2018)
• Specification and grade of Saposhnikoviae Radix (Saposhnikovia divaricata) (ScienceDirect, 2022)
• Chromones and coumarins from Saposhnikovia divaricata growing in Buryatia and Mongolia and their cytotoxicity (ScienceDirect, 2020)
• Saposhnikovia divaricata root and its major components ameliorate inflammation and altered gut microbial diversity in DSS-induced colitis (PubMed, 2023)
• Effects and potential mechanisms of Saposhnikovia divaricata on type I allergy and pseudoallergic reactions in vitro and in vivo (PubMed, 2023)
• Chemical constituents of roots of Saposhnikovia divaricata (PubMed, 2010)
• Saposhnikovia — Wikipedia
• Saposhnikovia divaricata (Apiaceae) — Important Species of Oriental Traditional Medicine: Current Research Status (ResearchGate / Botanica Pacifica, 2025)
• Simultaneous Determination of Five Chromones of Radix Saposhnikoviae Extract in Rat Plasma by UPLC-MS/MS (PMC, 2019)
• Traditional Chinese Medicine Ingredients — Health Canada (Government of Canada, Natural Health Products Ingredients Database)